A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein is a dataset published in Cell Reports (2025). On theSindex it has a DataRank of 0.399, placing it in the top 45.9% of the data-sharing corpus. It has been cited 8 times, with 6 citing works in its 1-hop citation network. Its calibrated FAIR score is 42/100.
Ranks in the top 46% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
“All reported data reported are publicly available at the CoVIC-DB ( https://covicdb.lji.org/ ).”
The paper gives a web address (URL) for the data, not a persistent identifier scheme (DOI, Handle, etc.). [majority verdict 'partial' (4/5 passes agreed)]
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“All reported data reported are publicly available at the CoVIC-DB ( https://covicdb.lji.org/ ).”
CoVIC-DB is a project-specific database, not a general purpose repository from the class-1 list, so it is a non-repository host. [majority verdict 'partial' (4/5 passes agreed)]
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
“All reported data reported are publicly available at the CoVIC-DB ( https://covicdb.lji.org/ ).”
The dataset identifier (URL) appears only in body text, not in the reference list. [majority verdict 'partial' (3/5 passes agreed)]
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“All reported data reported are publicly available at the CoVIC-DB ( https://covicdb.lji.org/ ).”
The data-availability statement points to a repository URL (CoVIC-DB), which is a link to archived data in a public repository (Colavizza category 3). [majority verdict 'yes' (3/5 passes agreed)]
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“we focus on 357 CoVIC antibodies that are single immunoglobulin G (IgG) products.”
The dataset content is described in running prose (e.g., the number of antibodies and their types) without an itemised inventory section, table, or list of files. [majority verdict 'partial' (2/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“All reported data reported are publicly available at the CoVIC-DB ( https://covicdb.lji.org/ ).”
The text gives a route to the data with no stated precondition; the data are publicly available. [majority verdict 'yes' (3/5 passes agreed)]
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“All reported data reported are publicly available at the CoVIC-DB ( https://covicdb.lji.org/ ).”
The paper states the data are publicly available, which is a synonym for open access label. [majority verdict 'yes' (3/5 passes agreed)]
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
The paper does not indicate the data are sensitive or require controlled access; data are publicly available.
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
“All reported data reported are publicly available at the CoVIC-DB ( https://covicdb.lji.org/ ).”
The text states the data are currently available but gives no persistence commitment. [majority verdict 'partial' (3/5 passes agreed)]
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format for the data is named in the paper.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
No data or metadata community standard (e.g., MIAME, BIDS) is named; only FAIR principles are mentioned without specifying a standard.
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
“SARS-CoV-2/human/USA/WA-CDC-WA-1 BEI Resources GenBank: MN985325”
The paper includes identifiers for external resources used (e.g., GenBank, PDB, RRID), which are not the study's own dataset.
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No license is stated for the data; the CC BY license applies only to the article, not the data.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
No version token or date is provided for the dataset in CoVIC-DB.
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
“This paper does not report original code.”
The paper states no original code was produced, so no code locator is given.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“We are grateful for INV-0006133 (E.O.S. and B.P.) and INV-008612 and INV-043419 (G.D.T.) from the 10.13039/100000865 Bill and Melinda Gates Foundation , 10.13039/100000002 NIH U19 AI142790-03S1 (E.O.S.) , and the 10.13039/100015595 GHR Foundation (E.O.S.) for supporting this study.”
Award/grant numbers are provided for the funding sources.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
“Carterra LSA HT-SPR instrument”
The paper names specific instruments and software used to produce the data, such as the Carterra LSA HT-SPR instrument. [majority verdict 'yes' (4/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“Table S1. CoVIC epitope community, in vivo survival, neutralization, affinity, and ACE-2 blockage data”
Variable-level definitions live inside the article as a supplementary table (Table S1), but no separate documentation object (README, codebook) is said to accompany the deposited data. [majority verdict 'partial' (3/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0690
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institutes of Health
Grant: U19 AI142790-03S1
Gates Foundation
Grant: INV-043419
Gates Foundation
Grant: INV-008612
Gates Foundation
Grant: INV-0006133
National Institutes of Health
Grant: 5U19AI142790-04
Consortium for Immunotherapeutics against Emerging Viral Threats
GHR Foundation
Otsuka Pharmaceutical
Shionogi
FWCI
6.59
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals